Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Amplifying Impact in AI
Description
The speaker discusses their advocacy journey in the context of artificial intelligence (AI) in dermatology, highlighting the importance of being proactive in shaping AI development to align with medical values and needs. They emphasize the rapid evolution of AI capabilities, the current lack of comprehensive regulation at the national level, and the fragmented state of AI oversight, which complicates compliance for developers and providers. The discussion covers the FDA's approach to AI tools and the challenges presented by the absence of guiding principles. The speaker outlines their committee's efforts to engage with stakeholders, establish ethical guidelines, and promote AI fluency among healthcare professionals. They stress the necessity of transparency, informed consent, and bias mitigation in both AI applications and medical practice. To foster trust, it’s crucial to critically analyze AI tools and understand their advantages and limitations. The talk concludes with a call to action, encouraging involvement in legislative processes and collaborative initiatives to ensure that AI serves to enhance, rather than undermine, the quality of patient care.
View moreConclusions
- Artificial intelligence (AI) tools are rapidly evolving and increasingly accessible in healthcare, particularly in dermatology.
- There is a critical need to develop a framework for ethical AI use, focusing on transparency, informed consent, and bias mitigation.
- Existing regulations around AI in healthcare are fragmented, leading to challenges in compliance and trust-building among patients and providers.
- The dermatology community is encouraged to engage with stakeholders to shape AI tools that align with humanitarian values and ethical standards.
- AI tools can enhance clinical decision-making but must be critically assessed for reliability and safety to minimize risks.
- Ongoing education and resources are necessary to improve AI fluency among dermatologists and ensure quality patient care.
- Collaborative efforts among medical societies can lead to robust guidelines for AI development and implementation in clinical settings.
- Agarwal, NBER, 2024
- Kim HE, Lancet Digital Health, 2020
- Rajpurkar P, NPJ Digital Medicine, 2020
- McDuff D, arXiv, 2023
- Goh E, JAMA Network Open, 2024
- Brodeur P, arXiv, 2024
- Wongvibulsin S, Lee I. Artificial Intelligence and Dermatology. JAMA Dermatol. Jan 8, 2025.